ResMed Inc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 56 trades in ResMed Inc (NYSE: RMD) since 2013, across 10 members, worth an estimated $1.2M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 31 buys against 25 sells, a modestly buy-led skew, with Democratic members responsible for 80% of the trades and Republican members 20%. The most recent disclosure shown was filed September 2026, and Rohit Khanna has filed the most RMD transactions among those shown, with 13. Other recent filers include Alan Armstrong. One notable disclosed move was a purchase by Rohit Khanna on June 16, 2026, up 17.7% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. ResMed Inc's current Quantellect Tide Score is 62 out of 100 (High Tide), Top 20% of universe (3990); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the ResMed Inc (RMD) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
ResMed congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
 Rohit Khanna House | Sep 4, 2026 | Aug 3, 2026 | 32 days | Buy |  $1,001 - $15,000 | +6.12% | Spouse | |
Rohit Khanna House | Jul 6, 2026 | Jun 30, 2026 | 6 days | Sell | $1,001 - $15,000 | +17.17% | Spouse | |
Rohit Khanna House | Jul 6, 2026 | Jun 16, 2026 | 20 days | Buy | $1,001 - $15,000 | +17.74% | Spouse | |
Rohit Khanna House | Jun 9, 2026 | May 27, 2026 | 13 days | Buy | $1,001 - $15,000 | +10.80% | Spouse | |
Rohit Khanna House | Jun 9, 2026 | May 15, 2026 | 25 days | Sell | $1,001 - $15,000 | +13.11% | Spouse | |
Rohit Khanna House | Jun 9, 2026 | May 1, 2026 | 39 days | Buy | $1,001 - $15,000 | +11.71% | Child | |
Rohit Khanna House | May 11, 2026 | Apr 24, 2026 | 17 days | Buy | $1,001 - $15,000 | +4.18% | Spouse | |
Rohit Khanna House | May 11, 2026 | Apr 13, 2026 | 28 days | Buy | $1,001 - $15,000 | -0.53% | Spouse | |
Rohit Khanna House | Apr 7, 2026 | Mar 30, 2026 | 8 days | Sell | $1,001 - $15,000 | +4.09% | Child | |
 Alan Armstrong Senate | Jul 21, 2026 | Mar 27, 2026 | 116 days | Buy | $1,001 - $15,000 | +3.88% | Self |
ResMed (RMD) congressional trading FAQ
Can members of Congress legally trade ResMed (RMD) stock?
Yes. Members of Congress are permitted to trade individual stocks, including ResMed (RMD), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional ResMed (RMD) trades public?
Yes. Every congressional trade in ResMed (RMD) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded ResMed (RMD)?
Members of Congress have disclosed 56 trades in ResMed (RMD) worth $1.2M across 10 members, according to public STOCK Act filings.
Which members of Congress have traded ResMed (RMD)?
Recent and active filers of ResMed (RMD) disclosures include Rohit Khanna, Alan Armstrong. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade ResMed (RMD) more?
Across disclosed ResMed (RMD) trades, 80% were by Democrats and 20% by Republicans, led by Democrats (80%).
What is the most recent congressional ResMed (RMD) trade?
The most recent disclosed ResMed (RMD) filing reported a buy by Rohit Khanna, filed Sep 3, 2026.
What is ResMed (RMD)'s Tide Score?
ResMed (RMD) has a Quantellect Tide Score of 62 (High Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.
Browse all stocks Congress tradesCongressional trading overviewResMed (RMD) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.